tag@treatmentactiongroup.org

HCV

Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?

  • Dorrit Walsh
On September 11 2021, Treatment Action Group’s Joelle Dountio Ofinboudem presented new data on the registration of the hepatitis C cure at the Conference on Liver Disease in Africa (COLDA) 2021. The presentation titled, “Have a Heart, Save My Liver! Who Has Access to the Cure in Africa,” explains that accelerating treatment uptake across Africa is urgently needed to meet WHO hepatitis C targets by 2030.
Read more

Long-Acting Technologies Resource Compendium

  • Dorrit Walsh

Our resource compendium is a non-exhaustive list of materials covering long-acting technologies to inform the hepatitis C, latent tuberculosis infection, and malaria scope of work under the LONGEVITY Project. Long-Acting Technologies Trials Tracker Illustrated Glossary for Long-Acting Technologies Select Scientific…

Read more
cover of the publication: Illustrated Glossary for Long-Acting Technologies, July 2021

Illustrated Glossary for Long-Acting Technologies

  • Dorrit Walsh
The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy. 
Read more

Launch of Public Health Partnership to Tackle the Silent Epidemic of Hepatitis C in Low- and Middle-Income Countries

  • Dorrit Walsh
The Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND, the global alliance for diagnostics, and the Treatment Action Group are joining forces to tackle a ‘silent’ public health injustice: the continuing disparities in access to diagnostics and treatment for the hepatitis C virus (HCV) in low- and middle-income countries (LMICs), home to 75% of those living with this viral illness.
Read more
Pipeline Report 2021 cover

2021 Pipeline Report

  • Dorrit Walsh
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Read more

Research in Action Awards 2021

  • Dorrit Walsh
On November 16, we honored CDC Director Rochelle Walensky, MD, MPH; Ivy Kwan Arce, activist, mother, and artist living with HIV; and Erica Lessem, MPH, former TAG Deputy Executive Director.
Read more
cover of TAG's 2020 annual report. It reads: progress in the fight for better treatment, prevention, a vaccine, and a cure for HIV, tuberculosis, and Hepatitis C virus

2020 Annual Report

  • Dorrit Walsh
As the HIV epidemic changes over time, and new pandemics continue to emerge, TAG continues to evolve while remaining true to our activist roots. We partner with the most affected communities in the U.S. and around the world.
Read more
Back To Top